stem cell therapy Archives - PharmaDeviceNews

What Matricelf’s Parkinson’s spinout reveals about the future of cell based neurodegeneration therapies

By Pallavi Madhiraju on March 8, 2026 Pharma & Biotech

Matricelf plans a subsidiary to commercialize its Parkinson’s therapy platform. Discover what this move signals for regenerative medicine and neurology innovation.

With AlloJoin Phase 3 in motion, Fosun Kairos takes lead on stem cell therapy rollout in China

By Pallavi Madhiraju on January 17, 2026 Pharma & Biotech

ElpasBio partners with Fosun Kairos to commercialize AlloJoin stem cell therapy for KOA in China. Find out what this deal means for the cell therapy market.

Medipost raises $140m to fund U.S. Phase III trial of stem cell therapy for knee osteoarthritis

By Pallavi Madhiraju on January 10, 2026 Pharma & Biotech

Medipost secures $140M to fund a pivotal U.S. Phase III trial in osteoarthritis. See how this could reshape the future of scalable stem cell therapies.